Carbapenem-resistant Enterobacteriaceae (CRE) are highly resistant bacteria that make treatment challenging even with strong antibiotics. These infections often arise in hospitals or in patients with weakened immunity and can cause serious illness. This category includes specialized antibiotic options designed to manage such difficult, high-risk infections, providing essential choices for advanced care.
